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Abstract
Background: Essential tremor (ET) and Parkinson’s disease (PD) are two of the most common movement disorders. Leaving aside their motor features, these two
conditions share several non-motor features, including cognitive dysfunction and personality changes. However, there are few data comparing the cognitive and
personality profiles of ET with PD. Here we compare the cognitive and personality profiles of the two diseases.
Methods: Thirty-two consecutive non-demented ET patients (13 females and 19 males) (67.7¡9.8 years), 32 non-demented PD patients (13 females and 19 males)
(67.7¡9.5 years), and 32 healthy matched controls (14 females and 18 males) (67.9¡10.1 years) underwent a neuropsychological test battery, including a global
cognitive assessment and tests of attention, executive function, memory, language, and visuospatial function, as well as the Personality Assessment Inventory.
Multivariable linear regression analyses were performed, adjusted for age, sex, years of education, medications that potentially affect cognitive function, number of
medications, and the 17-item Hamilton Depression Rating Scale Total Score.
Results: Neuropsychological scores were similar in PD and ET patients, but patients with disease performed more poorly than control subjects in cognitive tasks
such as attention, executive function, memory, and naming.
Discussion: ET and PD exhibited similar deficits in specific aspects of neuropsychological functioning, particularly those thought to rely on the integrity of
the prefrontal cortex, and this suggests involvement of frontocerebellar circuits. These findings further challenge the traditional view of ET as a benign and
monosymptomatic disorder.
Keywords: Essential tremor, Parkinson’s disease, neuropsychology, neurobehavioral manifestations, cognitive impairment, movement disorders, cerebellum,
thalamus
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Introduction
Essential tremor (ET) is one of the most common neurological
diseases.1,2 Traditionally, it has been considered a benign and mono-
symptomatic disorder characterized primarily by kinetic tremor in the
arms. However, an emerging view that is gaining wider support is
that it may actually be a family of diseases unified by the presence of
kinetic tremor, while also displaying etiological, pathologic, and clinical
heterogeneity.3–5 The biological mechanisms that underlie ET are not
entirely clear, although there is evidence that indicates that it may be a
neurodegenerative disease.6
In addition to motor manifestations, ET is also associated with a
number of non-motor manifestations, including depressive symptoms,7
changes in sleep patterns,8 and hearing impairment.9 Aside from the
above non-motor features, a proportion of ET patients show mild
cognitive deficits, mainly in attention and frontal executive function,
verbal memory, and visuospatial processes, which might be explained
by frontal cortical or frontal cortical–cerebellar pathway dysfunc-
tion.10–14 Of interest is that these cognitive deficits in ET might not be
static and appear to progress at a faster rate than those seen in normal
older people.13 Furthermore, patients with ET (especially late-onset ET)
appear to have an increased prevalence of mild cognitive impair-
ment and dementia15,16 and have a higher risk of incident
dementia.17
Cognitive dysfunction, even in the early stages, is one of the most
common non-motor features of another common movement disorder,
Parkinson’s disease (PD).18 In this neurodegenerative disease, cognitive
dysfunction is thought to be attributed to dysfunction of the basal
ganglia circuit (i.e., the striatal-thalamic-cortico loop) triggered by
deficits in dopaminergic nigrostriatal neurons.19 As reviewed in detail
elsewhere,20 several epidemiological studies have reported an elevated
odds or elevated risk of PD in patients with ET. These epidemiological
studies, which estimate measures of association, provide significant
controlled, quantitative evidence that ET is associated with PD and,
more specifically, that baseline ET seems to increase the risk of
developing PD by a factor of four to five.21–23
Despite the links between these two conditions, there are a limited
number of comparison studies of the cognitive profile of ET with
PD.24–30 Furthermore, these studies used small sample sizes and only
two of them utilized a complete neuropsychological examination.24,26
Further, only one study compared the personality features of both
diseases.31
In the present study, our aim was to compare the cognitive and
personality profiles of individuals with ET and PD, using a healthy
control group for additional comparison.
Methods
All procedures were approved by the ethical standards committees
on human experimentation at the University Hospital ‘‘12 de Octubre’’
(Madrid). Written (signed) informed consent was obtained from all
enrollees.
Participants
ET and PD patients were consecutively recruited from October
2012 to July 2013 from the outpatient neurology clinics of the Uni-
versity Hospital ‘‘12 de Octubre’’ in Madrid, Spain. Two neurologists
with expertise in movement disorders (J.P.R. and J.B.-L.) examined the
patients and used the Fahn–Tolosa–Marin Tremor Rating Scale to
assign a total tremor score tor the ET patients,32 and the Unified
Parkinson’s Disease Rating Scale (motor section) for those with PD.33
Diagnoses of ET and PD were assigned by these two neurologists using
the Consensus Statement on Tremor by the Movement Disorder
Society34 and the UK PD Society Brain Bank Clinical Diagnostic
Criteria,35 respectively. Furthermore, all ET patients had a normal
123 I-labelled N-(3-fluoropropyl)-2ß-carbomethoxy-3ß-(4-iodophenyl)-
nortropane single photon emission computed tomography scan. Patients
with a history of stroke, epilepsy, or head injury were excluded.
Furthermore, based on a detailed clinical mental status examination,
we excluded patients with Diagnostic and Statistical Manual of Mental
Disorders (DSM)-IV criteria for dementia.36 All ET and PD patients
underwent a detailed videotaped neurological examination. Each
videotape was reviewed by a senior neurologist specializing in move-
ment disorders (E.D.L.) who re-assessed ET or PD diagnosis using
the Consensus Statement on Tremor by the Movement Disorder
Society,34 and the UK PD Society Brain Bank Clinical Diagnostic
Criteria,35 respectively. The ET and PD patients were also followed at
regular intervals (3, 6, or 12 months, based on clinical need) and their
clinical assessment, described above, was repeated.
Healthy controls were recruited either from relatives or friends
of the health professionals working at the University Hospital ‘‘12 de
Octubre’’, Madrid (Spain), or among the relatives of patients who
came to the neurological clinics for reasons other than ET or PD
(e.g., headache, dizziness). None reported having a first-degree or
second-degree relative with ET. Each control was examined by two
neurologists (J.P.R .and J.B.-L.) to further rule out any neurological
conditions.
Procedure
During recruitment, patients and controls were told that the purpose
of the study was to complete a test battery to assess neuropsychol-
ogical and personality status. After the study had been described to
participants, informed consent to participate was obtained. Clinical
characteristics were also obtained from review of records from their
outpatient neurological care. All the neuropsychological and person-
ality tests were performed on the same day by the same examiner
(V.P.-M.).
All participants underwent a detailed neuropsychological assessment
covering the domains of attention, executive function, verbal memory,
visual memory, visuospatial ability, and language. These tests have
previously been described.37,38 They were selected in part to avoid the
effects of any hand tremor because they made minimal demands on
motor processes. Individual cognitive measures were grouped into
several cognitive domains, as described below.37,38
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Global cognitive performance was evaluated with the Spanish
version of the Mini-Mental State Examination (MMSE) (higher scores
indicate better cognitive performance).39
Attention and executive function were evaluated with a series of
tests. First, participants underwent the Direct and Indirect Digit
Span and the Coding-Digit Symbol subtests from the Wechsler Adult
Intelligence Scale—Third Edition (WAIS-III) (higher scores indicate
better cognitive performance).40 In the first, the examinee is required
to repeat three to nine digits forward (direct) and backward (indirect).40
In the second, the numbers one to seven have to be paired with
symbols on a key presented to the examinee.40 Second, the Similarities
subtest from the WAIS-III was also administered;40 in this test, which
examines concrete, functional, and abstract concept formation, 19 items
require the examinee to describe how two given things are alike.40
Higher scores indicate better cognitive performance.40 The Trail-
making Test is a measure of visuomotor coordination in which subjects
must connect circles in one form (A) on the basis of a simple rule of
consecutive numbers and in the second form (B) by alternating
between numerical and alphabetical sequences.41 For both forms,
A and B, the time for completion is the primary index of performance.
The score for this study was Trail B minus Trail A (lower scores
indicate better cognitive performance). Third, the Stroop Color–Word
Trial requires the participant to name the color of the ink in which a
colored word is printed.42 The task involves three test cards, one
containing rows of colored rectangles, with the task being to name the
colors as quickly as possible, one containing rows of color words
(printed in black ink), with the task being to read the words as quickly
as possible, and the third ‘‘interference’’ test consisting of rows of color
words printed in ink colors incongruent with the word represented,
with the task being to name the ink colors as quickly as possible.42 The
subject must ignore the word and name the color.42 The score for this
study was the interference effect (scores close to zero indicate better
cognitive performance). Fourth, the Wisconsin Card Sorting Test,
a test of ‘‘set-shifting,’’ requires the examinee to discern the sort criterion
of a set of cards based upon ‘‘correct’’ versus ‘‘incorrect’’ feedback
given by the examiner.43 The score for this study was the number of
errors and perseverations (higher scores indicate worse performance).43
Fifth, the Tower of London was administered, a well-known test used
for the assessment of executive function specifically to detect deficits in
planning.44 The test consists of two boards with pegs and several beads
with different colors.44 The examiner uses the beads and the boards to
present the examinee with problem-solving tasks.44 For this study, we
recorded the time required to execute the test.44 Finally, the Frontal
Assessment Battery (FAB), a brief tool designed to assess frontal lobe
function, including conceptualization, mental flexibility, motor pro-
gramming, sensitivity to interference, inhibitory control, and environ-
mental autonomy, was administered.45
To evaluate visuospatial ability, two tests were used. The first,
the Benton Judgment of Line Orientation Test, is a standardized test
of visuospatial skills, that measures a person’s ability to match the
angle and orientation of lines in space.46 The second, the Hooper
Visual Organization Test,47 is an instrument that measures visual
organizational skills, and consists of line drawing of simple objects that
have been cut into pieces and rearranged, such as in a puzzle. The
examinee’s task is to name what the object would be if the pieces were
put back together.47 In both tests, higher scores indicate better
cognitive function.46,47
To evaluate verbal memory, we used the Wechsler Memory Scale—
Third Edition (WMS-III) Word List,48 which included four learning
trials of 12 unrelated words. World List 1 is derived from the sum of
the four trials.48 A second list is then presented once for immediate
recall, following which the examinee is asked to again recall the first
list.48 Free recall and recognition (yes–no format) of the initial words
are later assessed after a delay interval.48 Higher scores indicate better
cognitive function.48
To evaluate visual memory, we used the Brief Visuospatial Memory
Test—Revised.49 In three learning trials, the examinee views the stim-
ulus page and is asked to draw as many of the figures as possible.49
A delayed recall trial is administered after a 25-minute delay.49 Last,
there is a recognition trial, in which the examinee is asked to identify
which of 12 figures were included among the original ones.49 Higher
scores indicate better cognitive function.49
Language was evaluated using the following tests. First, the Boston
Naming Test,50 which assesses the ability to name pictures of objects
through spontaneous responses and the need for various types of
cueing (lower scores indicate greater cognitive impairment). Second,
participants were asked to name as many items as possible from a
semantic category (animals) (semantic fluency) (lower scores indicate
greater cognitive impairment).51 Finally, the Controlled Oral Word
Association Test, a test that measures phonetic f luency, was admi-
nistered.52 Participants are provided with three letters of the alphabet
(F, A, and S), one letter at a time, and instructed to say as many words
as possible that begin with this letter in a 60-second interval.52 Higher
scores indicate better cognitive performance.52
Depression was assessed with the 17-item version of the Hamilton
Depression Rating Scale.53 Higher scores reflect more depressive
symptoms.53 The 17-item Hamilton Depression Rating Scale also
includes six items that assess anxiety features: psychic anxiety (Item 10),
somatic anxiety (Item 11), gastrointestinal somatic symptoms (Item 12),
general somatic symptoms (Item 13), hypochondriasis (Item 15), and
insight (Item 17).53
Psychopathology and personality symptoms were assessed using
the Personality Assessment Inventory (PAI), a widely used multi-
dimensional 344-item self-report measure.54 The PAI consists of
22 non-overlapping scales: four validity scales, 11 clinical scales, five
treatment consideration scales, and two interpersonal scales. For the
present study, only clinical scales (somatic concerns, anxiety, anxiety-
related disorders, depression, mania, paranoia, schizophrenia, border-
line features, antisocial features, alcohol problems, and drug problems)
were used, and higher scores reflect greater psychopathology.
All patients were using medications for their disease. Specifically,
propranolol and/or primidone for ET, and levodopa, rasagiline and/or
dopamine agonists for PD. The neuropsychological examination was
performed while taking their regular treatment.
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Statistical analyses
Statistical analyses were performed in SPSS Version 21.0 (IBM Corp.,
NY, USA). All tests were two sided, and significance was accepted at the
5% level (alpha50.05). Comparison of means of groups was made by an
analyses of variance (ANOVA) test for normally distributed data and by
a Kruskal–Wallis test for non-normally distributed data, where appro-
priate. The chi-square test was used to analyze differences in categorical
variables.
To assess differences between ET and PD patients, ET and control
subjects, and PD and control subjects in neuropsychological and
personality scores while adjusting for age, sex, years of education,
medications that potentially affect cognition function (i.e., anxiolytics,
stimulants, antipsychotics, antidepressants, antihistamines, antihyper-
tensives, or antiepileptics drugs), total number of medications, and
17-item Hamilton Depression Rating Scale Total Score, linear regres-
sion analyses were performed in which the outcome variables were
each one of the neuropsychological and PAI scores.
All test scores were normally distributed (Kolmorov–Smirnov test,
for all items, p,0.05), except for the MMSE, FAB, Direct and Indirect
Digit Span Tests, delayed recognition of the WMS-III Word List,
delayed recall and delayed recognition of the Brief Visuospatial
Memory Test—Revised, and perseverations of the Wisconsin Card
Sorting Test. For these latter tests that were not normally distributed,
a logarithmic transformation was performed prior to linear regression
analyses.
Results
Ninety-six participants were evaluated, with 32 in each of the three
groups. Clinical details of the patients and healthy controls are provided
in Table 1. The 32 ET patients (13 females and 19 males) were compared
with 32 PD patients (13 females and 19 males) and 32 healthy controls
(14 females and 18 males). The three groups did not differ to a significant
degree in terms of age, sex, years of education or intake of drugs with
effect on cognition (Table 1). However, there were differences in disease
duration (in years), as ET patients had had their disease for more time
(13.7 years more) than PD patients. Further, both ET and PD patients
were taking more medications than the control group. Our PD sample
comprised mild cases: 100% patients had a Hoehn–Yahr stage of I or II.
The raw mean scores on the different neuropsychological test are
detailed in Table 2. Significant differences between ET and PD were
not found in any test. In some tests, scores of ET patients were slightly
better than scores of PD patients, especially in the Trail-making Test
(Trail B minus Trail A), the Boston Naming Test, the Judgment of
Line Orientation Test, and the Hooper Visual Organization Test. PD
patients performed marginally better than the ET group in Simi-
larities, Wisconsin Card Sorting Test (perseverations), and phonetic
f luency. In other tests, the scores were similar in both groups.









Sex (women) 13 (40.6%) 13 (40.6%) 14 (43.7%) 0.959





















Taking a medication that
potentially affects cognition
function
10 (31.2%) 11 (34.4%) 6 (18.7%) 0.339









Values are expressed as mean (median)¡standard deviation, and range. Analysis of variance test or the Student t test were used for comparison of
continuous data where appropriate, and the chi-square test for proportions.
1Fahn–Tolosa–Marı`n Tremor Rating Scale for essential tremor and the Unified Parkinson’s Disease Rating Scale (motor section) for Parkinson’s
disease.
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patients (N 5 32)
Healthy controls
(N 5 32) p Bonferroni test
Global cognitive performance
Mini-Mental State Examination 33.0 (33.0)¡1.8 32.4 (32.0)¡2.0 34.2 (35.0)¡1.2 ,0.0011 ET,HC; PD,HC
Executive function and Attention
Direct Digit Span subtest from the WAIS-III 5.2 (5.0)¡1.2 5.2 (5.0)¡1.2 5.7 (6.0)¡1.2 0.2931 Not significant
Indirect Digit Span subtest from the WAIS-III 3.6 (3.5)¡1.1 3.6 (4.0)¡1.2 4.4 (4.5)¡1.0 0.0041 ET,HC; PD,HC
Coding-Digit Symbol subtest from the
WAIS-III 29.2 (25.5)¡14.9 30.2 (27.5)¡17.2 46.8 (46.0)¡16.2 ,0.001 ET,HC; PD,HC
Similarities subtest from the WAIS-III 12.4 (12.0)¡5.7 13.7 (11.5)¡7.0 17.7 (18.0)¡5.4 0.002 ET,HC; PD,HC
Trail-making Test, B – A 147.9 (137.0)¡101.6 178.3 (144.5)¡152.4 78.1 (60.5)¡71.8 0.004 EP,HC
Stroop Color–Word Trial (interference effects) -3.3 (-3.4)¡6.8 -4.3 (4.2)¡8.3 -1.7 (-2.5)¡7.5 0.401 Not significant
Wisconsin Card Sorting Test (errors) 60.6 (63.0)¡26.2 60.8 (65.0)¡22.3 59.1 (62.5)¡24.6 0.954 Not significant
Wisconsin Card Sorting Test (perseverations) 47.4 (31.0)¡39.4 40.4 (35.0)¡28.4 37.2 (32.0)¡26.5 0.9021 Not significant
Tower of London (time of execution in seconds) 454.5 (415.0)¡223.6 477.7 (456.0)¡268.4 357.0 (317.0)¡151.0 0.072 Not significant
Frontal Assessment Battery 15.4 (16.0)¡2.0 15.3 (16.0)¡2.1 17.2 (17.0)¡0.7 ,0.0011 ET,HC; PD,HC
Visuospatial ability
Benton Judgment of Line Orientation Test 9.6 (10.5)¡3.1 8.3 (8.0)¡3.6 10.1 (10.0)¡2.7 0.072 Not significant
Hooper Visual Organization Test 33.0 (33.5)¡8.4 28.4 (28.5)¡11.8 36.5 (36.0)¡9.0 0.007 PD,HC
Verbal memory
WMS-III Word List
Learning 25.3 (26.0)¡5.9 24.5 (24.0)¡7.3 28.0 (27.5)¡5.5 0.071 Not significant
Immediate recall 5.1 (5.0)¡2.3 5.6 (5.0)¡2.3 6.5 (6.0)¡1.9 0.047 ET,HC
Delayed recall 4.6 (4.5)¡2.1 4.9 (4.0)¡2.2 6.1 (6.0)¡2.3 0.020 ET,HC
Delayed recognition 20.6 (21.0)¡2.0 21.2 (21.5)¡2.2 22.1 (22.0)¡1.4 0.0081 ET,HC
Visual memory
Brief Visuospatial Memory Test—Revised
Learning trials 19.5 (18.0)¡8.7 20.2 (19.0)¡7.9 27.9 (27.5)¡5.3 ,0.001 ET,HC; PD,HC
Delayed recall trial 7.3 (8.0)¡3.4 7.4 (7.0)¡3.4 10.3 (10.5)¡1.6 ,0.0011 ET,HC; PD,HC
Recognition trial 11.4 (12.0)¡0.9 11.2 (12.0)¡1.1 11.8 (12.0)¡0.5 0.0251 PD,HC
Language
Boston Naming Test 44.6 (45.5)¡10.0 43.1 (46.0)¡11.7 52.1 (53.5) 5.4 ,0.001 ET,HC; PD,HC
Total number of animals as possible in
one minute 17.7 (15.0)¡8.0 18.5 (17.0)¡7.1 21.2 (21.0)¡6.0
0.128
Not significant
Controlled Oral Word Association Test 23.6 (19.5)¡13.1 26.7 (23.0)¡17.2 37.6 (40.5)¡12.8 ,0.001 ET,HC; PD,HC
Depressive symptoms
17-item Hamilton Depression Rating Scale
total score 6.4 (7.0)¡4.5 5.5 (6.0)¡4.16 5.0 (4.0)¡5.0 0.736 Not significant
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The performance of the ET group was worse than the control group
for most neuropsychological tests. These differences were significant
(ANOVA) for several tests: the MMSE, Coding-Digit Symbol subtest
from the WAIS-III, Indirect Digit Span subtest from the WAIS-III,
verbal memory (immediate recall, delayed recall, and delayed recogni-
tion), visual memory (learning trials and delayed recall trial), verbal
fluency, Boston Naming Test, FAB, and Similarities subtest from
the WAIS-III. In addition, the performance of the PD group was
worse than the control group for most neuropsychological tests. These
differences were significant (ANOVA) for several tests: MMSE, Trail-
making Test (Trail B minus Trail A), Coding-Digit Symbol subtest
from the WAIS-III, Indirect Digit Span subtest from the WAIS-III,
FAB, Hooper Visual Organization Test, visual memory (learning
trials, delayed recall trial, and recognition trial), verbal fluency, Boston
Naming test, and Similarities subtest from the WAIS-III.
In the linear regression analyses that were adjusted for age in years,
sex, years of education, medications that potentially affect cognition,
number of medications, and 17-item Hamilton Depression Rating
Scale total score, the results were similar to that of the ANOVA (Table 3).
The ET group did not differ from the PD group, and scored slightly
worse than the healthy control group in the FAB, Trail-making Test
(Trail B minus A), Coding-Digit Symbol subtest from the WAIS-III,
verbal memory (immediate and delayed recall, and delayed recogni-
tion), visual memory (learning trials and delayed recall trial), verbal
fluency, Boston Naming Test, and Similarities subtest from the WAIS-
III. The PD group performed more poorly than healthy controls in the
MMSE, FAB, Trail-making Test (Trail B minus Trail A), Coding-
Digit Symbol subtest from the WAIS-III, Hooper Visual Organization
Test, visual memory (learning trials, delayed recall trial, and recogni-
tion trial), Boston Naming Test, and Tower of London (time of execution).
In the PAI, we observed differences in the ANOVA tests between
the ET and the control group in somatic concerns, anxiety, and depres-
sion, where the ET group had higher scores (i.e., greater psycho-
pathology) (Table 2). The last two domains remained different in
regression models (Table 3). There were also differences between PD
patients and the control group in somatic concerns and depression, but
these differences were not observed in the regression analyses, except
for schizophrenia, borderline features, and drug problems. When we
compared the two diseases, there were differences in borderline
features, both in the ANOVA and the regression analyses. In addition,
there were differences between both diseases in anxiety-related dis-
orders and schizophrenia in the regression analyses.
We recognize that we entered many variables into the regression





patients (N 5 32)
Healthy controls
(N 5 32) p Bonferroni test
Personality and Psychopathology
Personality Assessment Inventory
Somatic concerns 13.0 (12.0)¡7.3 12.0 (11.0)¡6.3 7.6 (6.0)¡5.1 0.003 ET.HC; PD.HC
Anxiety 11.0 (10.0)¡6.9 8.2 (7.0)¡4.9 6.0 (5.0)¡5.3 0.005 ET.HC
Anxiety related disorders 14.1 (13.0)¡6.3 10.5 (10.0)¡5.4 10.4 (10.0)¡5.7 0.025 Not significant
Depression 10.6 (8.0)¡6.8 9.2 (8.0)¡5.0 5.6 (5.0)¡4.5 0.003 ET.HC; PD.HC
Mania 8.3 (8.0)¡5.5 6.2 (5.0)¡4.7 6.5 (6.0)¡4.2 0.207 Not significant
Paranoia 10.5 (9.0)¡4.4 8.7 (8.0)¡4.6 8.9 (9.0)¡4.3 0.218 Not significant
Schizophrenia 7.5 (7.0)¡5.9 4.6 (4.0)¡3.9 4.9 (4.0)¡3.5 0.029 Not significant
Borderline features 8.6 (7.0)¡5.4 5.3 (4.0)¡4.0 6.3 (7.0)¡3.9 0.018 ET.PD
Antisocial features 3.2 (3.0)¡2.7 2.7 (2.0)¡3.0 1.9 (2.0)¡1.6 0.150 Not significant
Alcohol problems 0.6 (0.0)¡1.4 0.2 (0.0)¡0.7 0.2 (0.0)¡0.6 0.140 Not significant
Drug problems 0.2 (0.0)¡0.6 0.1 (0.0)¡0.5 0.4 (0.0)¡1.0 0.199 Not significant
Abbreviations: ET, Essential Tremor; HC, Healthy Controls; PD, Parkinson’s Disease; WAIS-III, Wechsler Adult Intelligence Scale—Third Edition;
WMS-III, Wechsler Memory Scale—Third Edition.
Significant values are in bold font.
Mean (median)¡standard deviation is reported.
Analysis of variance test or 1Kruskal–Wallis U test.
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Table 3. Linear Regression Analyses Using Each Neuropsychological Test Score and the Personality Assessment Inventory as the Outcome







b p b p b p
Global cognitive performance
Mini-Mental State Examination 0.221 0.097 –0.119 0.281 0.367 0.004
Executive function and attention
Direct Digit Span subtest from the WAIS-III 0.012 0.929 –0.120 0.251 0.063 0.638
Indirect Digit Span subtest from the WAIS-III 0.216 0.086 –0.058 0.618 0.179 0.164
Coding-Digit Symbol subtest from the WAIS-III 0.370 ,0.001 0.018 0.831 0.343 ,0.001
Similarities subtest from the WAIS-III 0.285 0.013 0.029 0.734 0.208 0.054
Trail-making Test, B – A –0.323 0.017 0.171 0.195 –0.417 0.002
Stroop Color–Word Trial (interference effects) 0.118 0.422 –0.108 0.390 0.258 0.068
Wisconsin Card Sorting Test (errors) 0.108 0.389 0.050 0.690 0.049 0.697
Wisconsin Card Sorting Test (perseverations) 0.103 0.440 0.055 0.683 –0.018 0.891
Tower of London (time of execution in seconds) –0.180 0.137 0.079 0.519 –0.266 0.043
Frontal Assessment Battery 0.318 0.011 –0.033 0.789 0.391 0.003
Visuospatial ability
Benton Judgment of Line Orientation Test 0.092 0.453 –0.216 0.063 0.187 0.176
Hooper Visual Organization Test 0.183 0.157 –0.193 0.114 0.366 0.002
Verbal memory
WMS-III Word List
Learning 0.170 0.177 –0.079 0.472 0.176 0.154
Immediate recall 0.265 0.044 0.135 0.247 0.038 0.783
Delayed recall 0.279 0.026 0.065 0.576 0.174 0.187
Delayed recognition 0.312 0.013 0.150 0.293 0.221 0.128
Visual memory
Brief Visuospatial Memory Test-Revised
Learning trials 0.388 0.002 0.002 0.983 0.468 ,0.001
Delayed recall trial 0.380 0.003 0.002 0.989 0.430 ,0.001
Recognition trial 0.186 0.198 –0.208 0.123 0.318 0.018
Language
Boston Naming Test 0.297 0.013 –0.132 0.222 0.376 0.003
Category-cued Word Fluency 0.079 0.534 0.029 0.780 0.116 0.336
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variables that are generally used in research that evaluates cogni-
tion.55,56 In a sensitivity analysis, we removed several of the variables
(age, sex, and years of education) and the results were similar (data not
shown).
Discussion
In this study we characterized the cognitive performance of three
different groups: 32 ET patients, 32 PD patients, and 32 healthy con-
trols. Our goal was to compare the cognitive profile of PD and ET
using a healthy control group as a reference point. The importance of
this effort relies on the fact that that the three groups had similar age,
sex, and education. Moreover, previous studies on this topic have been
conducted in small samples, allowing us to benchmark these results
with our larger sample of individuals.
We observed that both the ET and the PD groups performed worse
than the control group. These results are in agreement with other
studies.24–26,29 ET and PD had similar deficits in specific aspects of
neuropsychological functioning, particularly those thought to rely on
the integrity of the prefrontal cortex, which suggests involvement of
frontocerebellar circuits,57 characterized by worse performance in
functions such as attention, executive function, memory, and naming.
Other studies have also noted these similarities between ET and
PD.26,28 Lombardi et al.24 studied 18 ET and 18 PD patients without
dementia, and compared the results with normative data. The ET
group showed a poorer performance only in verbal fluency tests and
digit span, whereas the PD patients, in addition, had a significantly
lower performance in visuospatial, memory, and attentional tasks.24
The authors suggested a frontosubcortical impairment for these find-
ings.24 Gasparini et al.25 reported data from a sample of 27 ET
patients (15 familial cases and 12 cases with a family history of PD),
15 PD patients, and 15 healthy controls, all of them without dementia.
The ET patients showed significant impairments both in attentional
and conceptual thinking tasks, similar to those observed in the PD
group.25 The authors suggested the presence of frontal lobe dysfunc-
tion in ET.25 Higginson et al.26 studied 24 ET patients, 24 PD patients,
and 21 healthy controls. The results indicated that the ET group
performed significantly worse than controls across multiple cognitive
domains, but performed remarkably similar to PD patients, consistent
with frontosubcortical dysfunction. A more recent study by Benge








b p b p b p
Controlled Oral Word Association Test 0.270 0.019 0.070 0.479 0.166 0.174
Personality and Psychopathology
Personality Assessment Inventory
Somatic concerns –0.223 0.093 –0.154 0.200 –0.051 0.694
Anxiety –0.230 0.033 –0.220 0.064 –0.022 0.874
Anxiety related disorders –0.123 0.311 –0.274 0.028 0.209 0.154
Depression –0.309 0.003 –0.134 0.186 –0.057 0.604
Mania –0.069 0.636 –0.194 0.153 0.041 0.791
Paranoia –0.114 0.413 –0.196 0.147 0.174 0.248
Schizophrenia –0.068 0.591 –0.256 0.026 0.296 0.039
Borderline features –0.073 0.559 –0.341 0.008 0.284 0.049
Antisocial features –0.230 0.081 –0.086 0.516 –0.116 0.405
Alcohol problems –0.120 0.421 –0.093 0.495 0.036 0.828
Drug problems 0.199 0.179 –0.082 0.578 0.299 0.044
Significant values are in bold font.
1Adjusted for age, sex, years of education, medications that potentially affect cognitive function, total number of medications, and 17-item Hamilton
Depression Rating Scale total score.
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brain stimulation candidates, including 15 PD patients and 11 ET
patients. The PD group had a poorer performance than the ET in that
scale and in the memory tests.30
In our study, PD patients performed more poorly than ET patients
and the controls in tests measuring global cognition and frontal
activities (i.e., FAB) and attentional, visuospatial, and denomination
tasks. On the other hand, the ET group scored marginally worse than
the PD group in memory, verbal fluency, and abstraction capacity.
When we compared the ET patients with the control group, they
performed less well in the same tasks as the PD group. However, in
multivariate analyses adjusted for confounding effects of age, sex, years
of education, number of medications, intake of drugs that may affect
cognition, and 17-item Hamilton Depression Rating Scale Total
Score, the results were similar between ET and PD patients. An
unexpected result, in multivariate analyses, was that schizophrenia
scores were higher in ET than PD. We do not have a biological
explanation for this result. As this was one of many differences, and
it was not reproducible in the ANOVA models after a Bonferroni
correction (see Table 2), it could be a spurious association. This is
furthermore supported by the observation that no prior studies have
reported an association between ET and schizophrenia/psychosis and
that there is no compelling biological/mechanistic basis to suspect a
higher incidence of psychotic disorders in ET patients.
Our findings suggest a similar cognitive profile for PD and ET
groups in the absence of dementia and, interestingly, an overlap in the
affected domains. In our opinion, these results highlight the existing
view that the PD and ET clinical picture exceeds motor features, even
at an early stage, where cognitive effects can be observed.14,18 Our PD
sample included mostly mild cases (100% had a Hoehn–Yahr stage of
I or II), reducing the possibility of cortical involvement, and the 5-year
mean disease duration also minimized the chances of a misdiagnosis of
dementia with Lewy bodies.
In PD, the cognitive features have been attributed to the dysfunction
of the basal ganglia circuit (i.e., the striatal-thalamic-cortico loop).19
Likewise, there is strong evidence that suggests a dysfunction of the
cerebello-thalamo-cortical circuit in ET.37,58 The thalamus is thought
to be highly implicated in modulation of cognitive performance,
representing a fundamental subcortical relay to the prefrontal cortex.59
The connections with the frontal lobes could be impaired in both
diseases and therefore explain the similar cognitive profile.18,19
The study was not without limitations. First, ET patients had a
longer disease duration than PD patients. This suggests that cognitive
impairment in PD might start before that in ET and that the cognitive
decline could be slower in ET. Second, the sample size was relatively
small. The literature, however, only includes studies with smaller
sample sizes. Further, despite the small sample size, our sample was
adequate to detect a number of robust differences between the patients
and the healthy control group. Third, the patients in the current study
may represent a selected group of ET or PD patients (i.e., patients seen
in selected outpatient clinics), and hence our results may not neces-
sarily be generalized to the entire ET or PD population. However,
in Spain, healthcare is fully state-subsidized, and community-dwelling
ET or PD patients are mostly seen by hospital-based and hospital-
associated neurologists. This study also had several strengths. First, this
is the first study that has assessed the cognitive and personality profile
at the same time in ET and PD patients. Second, assessments were
conducted prospectively in a standardized manner. Finally, the tests
included are reported to be among the most sensitive neuropsycho-
logical measures to detect cognitive impairment in tremor disorders.
In conclusion, our results are important for the definition and
characterization of the non-motor cognitive aspects of ET and PD. So
far, this study represents one of the largest samples where both condi-
tions were compared, hence being closer to the real cognitive perfor-
mance of both populations. The possibility to adjust for known confounding
covariates has also helped us to interpret these results. Interestingly,
we confirmed that both entities exhibited poorer cognitive perfor-
mance compared with healthy subjects, thus further challenging the
old mono-symptomatic motor view of ET.
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